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bstract
Evidence supports the benefits of exercise-based rehabilitation in promoting recovery in myeloma patients following autologous stem-cell
ransplantation (ASCT). However, ‘prehabilitation’ has never been evaluated prior to ASCT, despite evidence of effectiveness in other cancers.
tilising a mixed method approach the authors investigated the feasibility of a mixed strength and cardiovascular exercise intervention pre-
SCT. Quantitative data were collected to determine feasibility targets; rates of recruitment, adherence and adverse events, including 6 minute
alking distance (6MWD) test and patient reported outcome measures (PROMs). Qualitative interviews were undertaken with a purposive
ample of patients to capture their experiences of the study and the intervention. The authors recruited 23 patients who attended a mean
ercentage of 75% scheduled exercise sessions. However, retention rates were limited, with only 14/23 (62%) completing the programme.
n these patients, the 6MWD increased from a mean of 346 to 451 m (i.e. by 105 m, 95% CI 62 to 148 m) with no serious adverse events.
hist participants found the exercise programme acceptable and reported improvement in their physical fitness and overall mental health and
ellbeing prior to ASCT, the study identified challenges in hospital attendance for the prehabilitation schedule whilst receiving induction or
e-induction chemotherapy. Evaluation of digitally-enhanced directed but remote prehabilitation models for this patient group is warranted.
rial registration number NCT03135925
 2021 The Authors. Published by Elsevier Ltd on behalf of Chartered Society of Physiotherapy. This is an open access article under the CC
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ontribution  of  paper
This feasibility study demonstrated that:
 A recruitment target of two patients per month is feasible in a definitive trial.
 Minimum average attendance at exercise session of was 66%.
 There was an 80% retention to 6-week follow up assessment.
 Patients found the intervention acceptable however, challenges were identified in consideration to hospital attendance.
 There were no serious adverse events.
 Assuming a target difference of 30 m in the change in 6MWD walked between the groups; a standard deviation of 80 m; equivalent to a
standardised effect size of 0.38, 10% attrition, 90% power and 5% (two-sided) significance, a definitive trial would need to recruit and
randomise 336 participants.
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ackground
Multiple myeloma is a cancer characterised not only by
one marrow infiltration of malignant plasma cells (caus-
ng anaemia and other cytopaenias), but also frequently
idespread systemic features leading to variable degrees
f bone disease (with pain, fractures and hypercalcaemia),
mmunodeficiency, infections, and renal failure. For the
ajority of patients, myeloma remains an incurable condition
equiring sequential treatment of phases of disease activity.
ortunately, the number and types of available treatments
ave expanded over recent years and this has resulted in sig-
ificant improvements in survival, particularly in younger
ge groups, to the extent that myeloma may be considered
s a chronic relapsing-remitting disease in many patients
1]. Whilst many recently introduced therapies are ‘novel’
nti-myeloma agents, intensive consolidation with high-
ose melphalan and autologous stem cell transplantation
ASCT) continues to provide a cornerstone of routine first
ine myeloma treatment. Second or salvage ASCT (sASCT)
ow also features in routine care of well-selected myeloma
atients at first relapse in the modern era of treatment [2].
Despite improvements in survival, from the point of
iagnosis and treatment the cumulative effects of myeloma
ombined with treatment-related toxicities have a significant
mpact on quality of life and at many levels of normal func-
ioning [1,3–5]. Myeloma patients report more symptoms
nd limitations than those with other haematological malig-
ancies post treatment [1,4,6]. Myeloma is also a disease of
iddle and older age, and there is a progressive impact of
ge-related co-morbidities and frailty.
Few myeloma patients engage in the recommended
mounts of exercise during and following treatment and activ-
ty declines through treatment due to perceived barriers to
xercise including pain, fear of injury and fatigue. Those who
re sufficiently active before diagnosis of myeloma are more
ikely to be sufficiently active following treatment [7].
Rehabilitation following treatment in myeloma patients






trength and aerobic capacity; immunological function; psy-
hological outcomes and reduce fatigue [8]. Exercise training
or myeloma survivors has been shown to be safe and feasible
uring treatment with high attendance and adherence [9].
Studies demonstrate that patients pre-ASCT have reduced
xercise capacity and increased co-morbidities compared
ith a normal population yet most rehabilitative interven-
ions are focussed during and after treatment [10]. Cancer
rehabilitation is defined as; “a  process  on  the  continuum  of
are that  occurs  between  the  time  of  cancer  diagnosis  and  the
eginning  of  acute  treatment,  includes  physical  and  psycho-
ogical assessments  that  establish  a  baseline  functional  level,
dentifies impairments,  and  provides  targeted  interventions
hat improve  a  patient’s  health  to reduce  the  incidence  and
he severity  of  current  and  future  impairments"  [12]. Preha-
ilitation is a potential solution to improve outcomes for this
roup of patients. A review of prehabilitation in pre surgical
ancer patients [11] demonstrated the effective use of aerobic
nterventions in the management of patients undergoing tho-
acic surgery for lung cancer; identified the potential for its
se in other oncology settings and called for further research
o evaluate prehabilitation for wider groups of cancer patients
12].
In the ‘intensive’ pathway for younger myeloma patients, a
indow of opportunity exists to offer prehabilitation between
iagnosis and the commencement of ASCT – usually a period
f 4–6 weeks but this can be longer – during which time stem
ell harvesting takes place prior to admission for high dose
onditioning chemotherapy. Coleman et  al. [13] studied 24
yeloma patients undergoing a home based exercise pro-
ramme during chemotherapy and stem cell transplantation
nd identified that no patient injured themselves and that the
ntervention had positive effects on lean body weight, fatigue
nd sleep disturbance. They experienced high attrition rates,
ith 42% of patients leaving the study before completion.
o evidence currently exists regarding the use of prehabil-
tation exercise interventions in myeloma patients who are
ue to receive ASCT. The primary aim of this study was to
etermine the feasibility of proceeding to a definitive trial
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Assessed for e ligibili ty (n=95)
Excluded ( n=43)
♦ Not  meeting inclusion criter ia  (n=39) 
♦ De cli ned  to participat e (n=4) 
6-week follow- up(n= 14)
Baseline  assessment (n = 23) 6MWD score
(n=21)
Initial assessment (n= 23 )
Admission and  commenced  ASCT  (n=5)
Offered int ervent ion with  te lephone follow up  (n= 52)
6MWD score
(n=13) 
Discharge at  end of ASCT (n=4)
Declined
(n=29)
With drew(n=9) (health  iss ues n=2,  time 
commitment  n=1, commenced 





























ig. 1. Participant flow diagram.
f a mixed strength and cardiovascular exercise intervention
efore ASCT.
ethods
A mixed quantitative and qualitative data collection and
nalysis with a prospective feasibility study design was
ndertaken [14]. The full methodological details with sam-
ling, inclusion and exclusion criteria and intervention have
een published in the study protocol [15]. All patients with
ultiple myeloma who were awaiting ASCT (including first
nd second transplantation) were eligible to be invited to
articipate in this study. At the time of the study, this was
pproximately 70–80 patients per year. Assuming 70% of
his population fulfil the inclusion criteria; this would give
round 49–56 eligible patients per year; if 50% of eligible
atients consent to take part in the study then the authors
stimated to be able to recruit between 24 and 28 patients
er year. Thus, in order for a definitive trial to be feasible the
uthors think the authors need to recruit eligible myeloma
4
atients at a minimum recruitment rate of two per centre per
onth; i.e. 24 per year.
Ultimately, a total of 23 patients were recruited in 13
onths however, nine withdrew (see Fig. 1) resulting in a
mall sample size of 13 for analysis.
ims  and  objectives
The primary aim of this study was to determine the feasi-
ility of proceeding to a definitive trial. The study objectives
ere to:
. Assess the acceptability of the study to patients by mea-
suring recruitment and retention to the study and through
qualitative interview responses.
. Explore reasons for non-consent to study participation.
. Establish whether a target cohort of patients exists.. Determine the most appropriate recruitment points post
diagnosis through, steering group feedback, the recruit-
ment rate when compared with numbers invited to join
the study and qualitative interview reports.
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Table 1
Intervention description and replication check list (TiDieR).
Item Description
1 Brief name Myeloma pre-habilitation exercise
2 Why The interventions was based on mixed exercise programmes which have been shown to be safe and effective in
myeloma survivors
3 What, materials and
procedures
Materials:
static exercise bike; treadmill; seated rowing machine; handheld weights; resistance equipment; heart rate
monitor; gym ball; wall bars; wobble board
Procedures:
- cardiovascular exercises (treadmill, exercise bike, seated rowing machine)
- upper and lower limbs strengthening exercises using body weight, handheld weight or resistance equipment
- balance and core stability exercises
4 Who provided Specialist physiotherapists with expertise in haematological conditions and exercise rehabilitation. Therapy
assistants and non-specialist physiotherapists (under the supervision of specialist physiotherapist).
5 How Face to face group exercise classes
6 Where Physiotherapy gym within an acute hospital
7 When and how much Up to six weekly sessions lasting 1 hour, including warm up and cool down.
Each participant completed their individualised exercise program during the allotted time.
Participants wore heart rate monitors and were advised to maintain their heart rate within a pre-calculated target
range.
8 Tailoring All participants were given an individualised exercise program to meet their needs and abilities. Programs were






































0 How well NA
. Assess the suitability of inclusion and exclusion criteria
by examining recruitment data.
. Assess the acceptability of the intervention through qual-
itative interviews and retention rates during the study.
. Determine duration of the intervention before transplan-
tation commences by monitoring point of recruitment to
the study and time to transplant.
. Explore the appropriateness of outcome mea-
sures/completeness by qualitative interview responses,
completion rates and time to complete.
xercise  intervention
The intervention consisted of an individualised, super-
ised exercise programme. Exercises were tailored to meet
articipants’ ability, as identified by initial assessment by the
hysiotherapist. The exercise programme consisted of a com-
ination of exercises completed in a circuit by participants:
 cardiovascular exercises (treadmill, exercise bike, seated
rowing machine),
 upper and lower limbs strengthening exercises using body
weight, handheld weights or resistance equipment,
 balance and core stability exercises.
Participants undertook a warmup and cool down at the start
nd end of each session. Participants wore heart rate moni-
ors throughout the exercise programme and were advised
o maintain heart rate within a calculated target range [16].




ctivity on an exercise log sheet – this included number of
epetitions, duration, any added resistance and the perceived
ffort. Exercise programmes were regularly reviewed and
rogressed or modified in line with participants’ abilities.
The intervention was 6 weeks and occurred before patients
nderwent their ASCT. Participants may have subsequently
ndergone rehabilitation after their ASCT, but this was not
aptured in the study data (Table 1).
easibility  outcomes
Feasibility outcomes were set as follows; 1) Recruitment
arget of two patients per month. 2) Minimum average atten-
ance at exercise session of 66%. 3) 80% retention to 6-week
ollow up assessment. 4) Patient acceptability. 5) Adverse
vents.
linical  outcomes
This was assessed with six-minute walk distance test
6MWD). The six minute walk test is a useful field test of
unctional capacity, is safe to administer and although has
ess correlation with peak oxygen capacity than the shuttle
alk test, it is better tolerated by patients and is more reflec-
ive of activities of daily living as it is a submaximal exercise
est [17] The six minute walk test has been found to be a valid
nd reliable test in patients with cancer [18].
Two sets of patient reported outcome measures (PROMs)
ere also assessed during the study; patients were allocated
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Table 2
Two sets of PROMs assessed in the study.
PROMs 1 PROMs 2
Category Measure Category Measure
Physical activity/fitness International Physical Activity Questionnaire Physical activity/fitness Godin Leisure Time
M e Mental wellbeing Warwick - Edinburgh mental well-being scale
Q Quality of life EORTC QLQ C30 MY20




































Myeloma diagnosis time (in years) summary statistics of the patients
(N = 22).








Recruitment rate summary statistics.
Summary Recruitment rate/month
Mean 1.8


























ental wellbeing Warwick – Edinburgh mental wellbeing scal
uality of life FACT– MM 
elf-efficacy with exercise SCI self-efficacy for exercise scale 
o complete one set of PROMs only (Table 2). Patients were
llocated on an alternating basis to the two PROM groups
ased on the order in which they were recruited
The patient reported outcome measures used in the study
ere selected through PPI consultation. A focus group
ttended by three patients (1 pre-transplantation and 2 post-
ransplantation) was conducted in which study design was
iscussed, including a selection of proposed outcome mea-
ures. Representatives helped to identify the domains which
hey felt should be assessed, and the questionnaires which
ight be most effective.
ualitative  interviews
Patients who decline to take part in the exercise trial were
sked if they would undertake a short telephone interview to
scertain their reasons for not taking part in the study. Par-
icipants who had been consented to take part in the trial and
ere undertaking the exercise programme were approached
y a member of the clinical team and asked if they would
e interested in taking part in a series of face-to-face or tele-
hone interviews. Only two patients declined to take part in
he qualitative interviews. The interviews were undertaken
y an independent qualitative researcher.
esults  and  analysis
emographics
The authors recruited 23 patients (mean and median age
5, range 53–78 years) over 13 months at a single centre
Sheffield Teaching Hospitals NHS Foundation Trust). The
ender was similar between the two PROMs groups, (70%
ale, 30% female), but age was slightly higher in group 1
mean 66.2, median 66 years) and lower in group 2 (mean
3.0, median 60 years).
yeloma  characteristics
Table 3 presents summary statistics on the length of time
ince the patient was diagnosed with myeloma.easibility  outcomes
ecruitment.  Fig. 1 presents the participant flow diagram for
he study. The study started with 95 potential participants, of








n the study and a further 29 declined when offered the inter-
ention. The study recruited 23 patients (19 first ASCT, four
ASCT) who attended baseline exercise sessions. Of these
3, 21 completed the 6-minute walking distance (the primary
ndpoint). At week 6, there were 14 patients remaining, of
hich 13 completed the 6MWD. The study aimed to collect
ata at the start and end of the transplant; data was collected
rom five patients at the start and four at the end.
The target recruitment was two patients a month for 12
onths, therefore a total of 24 patients. The study recruited
3 patients over 13 months a rate of 1.8 patients per month
Table 4). The recruitment rate for the study was slightly
nder the target rate for most of the 12 month period.
onthly recruitment  rate
xercise  session  attendance.  The second feasibility crite-
ia were to evaluate a minimum attendance rate of 66% for
he exercise sessions. This was calculated using the number
f sessions the patient was scheduled to attend. Occasional
atients underwent ASCT sooner than the schedule could
ccommodate so were unable to complete the six sessions.
able 5 presents the summary statistics for the number and
ercentage of sessions attended. Mean and median number
f sessions attended (4.5 and 5.0 respectively) exceeded the
arget of four sessions. The authors recruited 23 patients who
ttended a mean percentage of 75%, median 75% of their
cheduled exercise sessions. The target percentage was 66%.
S. Mawson et al. / Physiothera
Table 5
Summary statistics for the number of sessions attended.


























































































QR (3.0, 6.0) (58%, 100%)
in 1 25%
ax 6 100%
ata showed that mean attendance was 4.5 weeks, with 11
articipants attending for the full 6 weeks.
etention  and  attrition  rate.  The study aimed to have a reten-
ion rate of at least 80%. This value was calculated using the
atients who had a 6MWD at baseline and follow up as this is
otentially the primary end point of the study. The retention
ate in the study was 57% (13/23) which is lower than the
arget of 80%.
dverse events  (AE).  Another feasibility criterion was the
ncidence of AE. There were 136 sessions in total (after the
nitial session) with one adverse event. Therefore, the mean
umber of adverse events was 0.01 with a 95% confidence
nterval of (0.00, 0.04).
erious  adverse  events  (SAE).  The final feasibility criterion
as the incidence of SAEs. There were no SAEs in the 136
essions in total (after the initial session).
easibility  criteria  summary
Table 6 shows the different feasibility targets and whether
hey were met, almost met, not met.
linical  outcomes
Outcome scores all changed from baseline to the 6 week
ollow up (see Table 6). When assessing clinical outcomes it
s important to understand what the is Minimally Clinically
mportant Difference (MCID) for each outcome used [19]. As
 comparator, the only outcome to have a MCID is the 6MWD
here a difference of 25–35 m (m) is considered clinically
eaningful for patients with Chronic Obstructive Pulmonary
isease (COPD) [20].
Whilst this feasibility study did not set out to explore the
CID for each PROMs used the results suggest that a number
f the scores changed over time with improvements in some
cores (see Table 7). However, further analysis is underway
o establish if these changes were meaningful to this patient
roup.
The primary outcome for the study was the 6MWD,
hich had an initial mean score of 346 m and a final mean





py 113 (2021) 88–99 93
ssessments, a mean increase in distance of 105 m (95% t-
istribution confidence interval 62 to 148 m). Table 6 also
ummarises the changes in a wide range of PROMs, which
enerally reflect improvement in function and quality of life
ith the exercise programme. Paired t-tests were conducted
n all the clinical outcomes to determine the direction of any
ffects. It is important to note that the analysis is not pow-
red to detect any significant differences as this is a feasibility
tudy and no sample size calculations were performed prior
o the study. Both parametric and non-parametric tests were
erformed and agreed.
ample  size  for  the  main  RCT
The primary outcome for the main RCT is the change in
istance walked, on the 6MWD, from pre to post rehabili-
ation, that is from baseline to the 6 weeks follow up (see
ig. 1). This feasibility study saw a change (mean increase)
f 105 m (95% CI 62 to 148) in the 6MWD test from baseline
o the 6 week follow up post the rehabilitation intervention
n the 13 participants who had pre and post 6MWD data. The
inimum importance distance (MID) for the 6MWD is vari-
ble depending on the condition/population it is being used
or, and varies between 14 and 40 m [20–22]. The standard
eviation for the change in distance walked pre to post reha-
ilitation was observed to be 71 m (95% CI 51 to 118). The
tandard deviation of the post rehabilitation distance walked
as 81 m (95% CI: 58 to 133).
The recruitment rate was estimated to be 1.8 patients per
onth. It has been suggested that recruitment rates within a
ospital setting is likely to be 1.24; with this in mind the sam-
le sizes have been calculated using conservative recruitment
ate estimates of one and two patients per month.
If the authors assume a target difference of 30 m in the
hange in 6MWD walked between the groups; a standard
eviation of 80 m; equivalent to a standardized effect size of
.38, 10% attrition, 90% power and 5% (two-sided) signifi-
ance, then the main trial would need to recruit and randomise
36 participants.
Table 8 shows that a target sample size of 336 participants
ith a recruitment rate of two patient/centre/month and 24
onths of recruitment; the authors would need a seven centre
rial.
The protocols for the qualitative data collection and anal-
sis have been reported in the previously published study
rotocol [15]. The framework approach was used to analyse
he qualitative data. This method is appropriate for identi-
ying, analysing, and reporting themes and patterns within
ata. It is a flexible and useful research tool, which can poten-
ially provide a rich and detailed, yet simple account of data.
arly on in the analysis the transcripts were repeatedly read
o develop an understanding of the breadth and depth of the
ata. During this process, data were labelled and coded in an
terative process whereby patterns and sequences of content
ver time were identified within and across all the partici-
ants. Emergent themes were further developed and refined
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Table 6
Feasibility targets.
Target Mean 95% confidence
interval
Target met?
Recruitment target of two
patients a month




75% (65.8, 84.1) Met. The mean is above the target and the confidence interval contacts the target.
80% retention to 6 weeks 62% (40.9, 79.2) Not met. The mean is less than the target and the confidence interval is below the target.
Adverse events 0.01 (0.00, 0.04) There was one adverse event out of 136 sessions. The adverse event was due to a long
standing condition, which the exercise sessions aggravated. The remaining sessions were


































































erious adverse events 0  (0.00, 0.03) Met. Th
a This percentage was calculated from the number of sessions the patient 
eceiving the transplant early.
y analysing similarities and divergences between and within
he participants, to form a coherent pattern.
atient  acceptability
on-participants
Of the 33 patients that declined to take part in the exercise
rogramme, all were approached and six agreed to undertake
 short telephone interview to discuss the reasons for non-
articipation.
The distance to get to the venue, and the location of
he venue, was cited as one of the main reasons for non-
articipation in the study. The impact of feeling fatigued and
ot being able to manage other activities within the context
f daily living and living with myeloma were also cited dur-
ng the telephone interviews. Four of the six patients lived
utside city boundaries and consequently travelling was an
ssue, as illustrated by the following quote:
The main reason is I don’t drive, I live in (place) and it would
ean getting a train and then a bus’ (TP1).
However, distance alone was not always the sole reason
nd four patients described how having to manage atten-
ance at clinical appointments, alongside travel time, also
ontributed to their decision to not take part.
articipants
Of those taking part in the exercise programme, seven
articipants initially agreed to take part in the qualitative
omponent of the study. Semi-structured interviews were
onducted with a purposive sample of four participants
ho had completed the exercise programme prior to ASCT.
hree participants were not contactable by telephone. The
esearcher met the participant at the penultimate exercise ses-
ion. This enabled confirmation of consent to participate and
he first interview date and time to be arranged.
It had been intended that interviews would be conducted
t a number of time points: following completion of the exer-
ise programme, prior to ASCT and post ASCT. This would
apture the perspectives of the participants’ over time, specif-




e no serious adverse events in the study.
eduled to attend. The target of six sessions was difficult with some patients
ecame clear that for some participants that there was a short
ime frame between the exercise programme and the trans-
lantation, therefore the decision was taken to complete two
nterviews, following the exercise programme and following
SCT. However, a number of factors influenced the ability
f the participants to undertake two interviews, for example,
he impact of the illness or the timing of ASCT post exercise
rogramme.
xperience  of  the  exercise  programme
All the participants talked positively about their expe-
ience of the exercise programme. All of them felt well
upported by the physiotherapists in that they were given
xercises that were appropriate to their level of fitness and
apability. Furthermore, the participants were given detailed
nstruction on how to undertake the exercises, and also how
o improve their technique and fitness. This contributed to
ncreasing the participants’ ability to engage with the pro-
ramme, as illustrated by the following quote:
They were good at sorting technique. All of them were
ttentive and made sure you were okay’ (P3).
One participant encountered challenges getting to the
ym, especially when this meant travelling to the hospital
or an extra day in the week. Also, the timing of the class
eant that it was difficult to plan other activities in the day.
his participant would have preferred an individually tailored
rogramme of exercise that they could practice at home, with
 reduced number of gym visits.
All of the participants described how the exercise pro-
ramme had improved their level of fitness and stamina.
nitially three participants struggled with the exercises as
alking had been problematic due to bone pain and neuropa-
hy. However over the six week programme their reported
obility had improved along with ability to manage the exer-ises more effectively.
All participants reported that the exercise programme had
mproved confidence, overall mental health and wellbeing,
















6MWD and PROMs baseline to 6 week follow up.
N Initial Final Mean change (SD) 95% CI Median change IQR
Mean (SD) Mean (SD)
Median (IQR) Median (IQR)
6 minute walking
distance (m)
13 346.9 (100.9) 451.8 (80.7) 104.9 (71.4) 61.8, 148.1 98 53.0, 145.0
380 (320,390) 443 (405, 495)
IPAQ 6 2678 (2990) 3812(3842) 1134 (2223) −1199, 3466 1622 −367, 2850
1939 (586, 3170) 2638 (1408, 3995)
Godin 7 19.9 (29.5) 34.0 (41.8) 14.1 (17.7) −2.3, 30.5 9 0.0, 21.0
3.0 (1.5, 26.5) 18.0 (6.0, 52.0)
WEMWBS 12 47.5 (12.7) 50.8 (10.9) 3.4 (7.5) −1.4, 8.2 3.5 −2.0, 7.0
47.0 (38.0, 56.0) 51.5 (47.8, 56.8)
ESES 13 28.7 (5.8) 30.2 (6.2) 1.5 (5.6) −1.9, 4.9 2 −1.0, 4.0
27.0 (25.0, 35.0) 30.0 (28.0, 36.0)
FACT-MM-TOI 6 63.0 (25.3) 71.0 (14.5) 8.0 (28.3) −21.7, 37.7 −2 −7.5, 8.8
68.5 (55.3, 76.5) 73.0 (60.8, 80.8)
FACT-G 6 68.3 (19.7) 65.5 (18.3) −2.8 (12.3) −15.7, 10.0 −0.5 −5.5, 6.0
70.5 (67.3, 73.0) 69.0 (52.8, 74.0)
FACT-MM 6 98.8 (34.2) 102.7 (19.5) 3.8 (31.9) −29.6, 37.3 −1.5 −11.3, 9.0
107.0 (94.8, 113.3) 98.5 (93.3, 111.3)
EORTC QL2 5 62.5 (27.8) 69.4 (19.5) 6.7 (23.9) −23.0, 36.3 8.3 −8.3, 25.0
66.7(54.2, 72.9) 75.0 (56.3, 81.2)
EORTC PF2 7 62.9 (27.2) 76.0 (20.5) 13.1 (8.6) 5.1, 21.1 13.3 9.2, 16.7
66.7 (46.7, 80.0) 80.0 (60.0, 92.5)
EORTC RF2 7 54.8 (45.9) 71.4 (36.9) 16.7 (19.2) −1.1, 34.5 16.7 0.0, 25.0
50.0 (16.7, 100.0) 100.0 (41.7, 100.0)
EORTC EF 5 80.6 (20.2) 84.7 (12.3) 5.0 (12.6) −10.7, 20.7 0.0 0.0, 8.3
83.3 (83.3, 89.6) 87.5 (77.1, 91.7)
EORTC CF 5 66.7 (33.3) 88.9 (8.6) 20.0 (29.8) −17.0, 57.0 0.0 0.0, 33.3
66.7 (50.0, 95.8) 83.3 (83.3, 95.8)
EORTC SF 5 38.9(39.0) 55.6 (39.0) 10.0 (14.9) −8.5, 28.5 0.0 0.0, 16.7
















N Initial Final Mean change (SD) 95% CI Median change IQR
Mean (SD) Mean (SD)
Median (IQR) Median (IQR)
EORTC FA 7 56.4 (32.5) 34.1(27.3) −22.2 (29.9) −49.9, 5.4 −11.1 −36.1, 0.0
50.0 (44.4, 77.8) 33.3 (16.7, 44.4)
EORTC NV 7 7.1 (13.1) 11.9(18.6) 4.8 (8.1) −2.8, 12.3 0.0 0.0, 8.3
0.0 (0.0, 8.3) 0.0 (0.0, 16.7)
EORTC PA 7 42.9 (45.0) 42.9 (25.2) 0.0 (25.5) −23.5, 23.5 0.0 −16.7, 16.7
33.3 (0.0, 83.3) 33.3 (33.3, 66.7)
EORTC DY 7 61.9 (40.5) 28.6 (40.5) −33.3 (33.3) −64.2, −2.5 −33.3 −33.3, −16.7
66.7 (33.3, 100.0) 0.0 (0.0, 50.0)
EORTC SL 7 23.8 (25.2) 38.1 (23.0) 14.3 (26.2) −10.0, 38.5 33.3 0.0, 33.3
33.3 (0.0, 33.3) 33.3 (33.3, 50.0)
EORTC AP 7 19.1 (26.2) 33.3(33.3) 14.3 (32.5) −15.8, 44.4 0.0 0.0, 33.3
0.0 (0.0, 33.3) 33.3 (0.0, 66.7)
EORTC CO 7 33.3 (38.5) 9.5 (16.3) −23.8 (37.1) −58.1, 10.5 0.0 −33.3, 0.0
33.3 (0.0, 50.0) 0.0 (0.0, 16.7)
EORTC DI 5 5.6 (13.6) 5.6 (13.6) 6.7 (14.9) −11.8, 25.2 0.0 0.0, 0.0
0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
EORTC FI 5 5.6 (13.6) 5.6 (13.6) −6.7 (14.9) −25.2, 11.8 0.0 0.0, 0.0
0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
EORTC MYFP 4 62.2 (41.3) 61.1 (21.3) −2.8 (26.3) −44.6, 39.0 −11.1 −22.2, 8.3
55.6 (55.6, 100.0) 66.7 (50.0, 77.8)
EORTC MYBI 4 66.7 (47.1) 75.0 (31.9) 16.7 (19.3) −14.0, 47.3 16.7 0.0, 33.3
100.0 (33.3, 100.0) 83.3 (58.3, 100.0)
EORTC MYDS 6 30.6 (22.4) 18.9 (16.8) −11.3 (5.2) −16.8, −5.8 −11.1 −15.3, −6.9
30.6 (12.5, 44.4) 16.7 (5.6, 30.0)
EORTC MYSE 6 18.8 (10.6) 12.9 (11.3) −6.1 (4.5) −10.8, −1.4 −3.3 −8.3, −3.3
20.0 (12.5, 27.2) 13.3 (3.3, 21.7)
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Table 8
Sample size with target difference of 30 m in the mean difference in the change in distance walked with an SD of 80 m and 90% power and 5% two-sided

















1 5% 90% 80 30 0.38 336 12 28
1 5% 90% 80 30 0.38 336 18 19
1 5% 90% 80 30 0.38 336 24 14
1 5% 90% 80 30 0.38 336 30 12
1.5 5% 90% 80 30 0.38 336 12 19
1.5 5% 90% 80 30 0.38 336 18 13
1.5 5% 90% 80 30 0.38 336 24 10
1.5 5% 90% 80 30 0.38 336 30 8
1.8 5% 90% 80 30 0.38 336 12 16
1.8 5% 90% 80 30 0.38 336 18 11
1.8 5% 90% 80 30 0.38 336 24 8
1.8 5% 90% 80 30 0.38 336 30 7
2 5% 90% 80 30 0.38 336 12 14
2 5% 90% 80 30 0.38 336 18 10










































 5% 90% 80 30 0.3
It proved that I was capable of doing things, it made me more
ositive that in the future I may get some of my health back,
aybe I will be able to play badminton again. Suddenly all
our social life goes out of the window especially if it has
een sports based, you don’t do it anymore and it leaves big
aps’ (P2).
ompleting  exercise  logs
All of the participants logged their exercise activity dur-
ng their gym sessions, although initially some had needed
ssistance. Although three participants highlighted that the
orms demonstrated some improvement in their perfor-
ance/fitness, they felt the forms did not totally capture the
mprovement. As participant two described:
Sometimes the form didn’t reflect that I was getting better. I
ould set off and do 5 minutes on the exercise bike, I found
hat easy so they upped it to 10 minutes. I’d still say breath-
essness 12 or whatever, but that’s because I was doing twice
s long on the machine so you would have to read the form a
ittle more carefully to see I was actually upping the duration
f what I was doing. So maybe that needs building into the
orm in some way’. (P2)To address this issue, three participants mentioned that it
ould be useful to have space on the form to note where






ncreased level of difficulty. One participant stated how they
ad written on the form where they spent longer on an activity
o that the improvement in stamina could be seen.
iscussion
This study has assessed all the feasibility criteria out-
ined in the original protocol, demonstrating that recruitment
s feasible, with 74.9% of participants attending scheduled
xercise sessions. However, the retention rate was below the
equired rate of 80% with only a 57% retention rate. Whilst
he authors have been able to calculate a sample size and
ampling period with seven recruiting centres the qualitative
ata highlighted a number of issues with the model of reha-
ilitation being provided in this feasibility study. Participants
ound the exercise programmes acceptable and four partic-
pants interviewed felt the programme had improved their
hysical fitness and enhanced their overall mental health and
ellbeing.
Whilst there were improvements in a wide range of
ROMs, which generally reflected improvement in func-
ion and quality of life the observed improvement in the
MWD by a mean of 105 m (95% confidence interval 62
o 148 m) is encouraging, with no serious adverse events.
s the MCID for the 6MWD is between 14 and 40 m,
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ul [21–23]. However, despite the potential benefits, it is very
lear that some participants encountered challenges in attend-
ng the hospital for the prehabilitation programme during
heir induction/re-induction chemotherapy in the run up to
SCT (mean attendance was 4.5 weeks). The sample size
or the qualitative interviews was small and data saturation
as not achieved, this being a limitation of the study.
A recent UK policy document relevant globally for reha-
ilitation models [24] recommends the need for public health
ervice providers to support more flexible rehabilitation path-
ays that allows patients to move from ‘acute complex
pecified rehabilitation’ to different phases of specialist reha-
ilitation within their region or local community.
As some of our participants found it difficult to attend
or acute complex specialist rehabilitation, there is a need
o explore the potential benefits of local rehabilitation,
hich would alleviate the problems identified in travel-
ng to acute hospital services during induction/re-induction
hemotherapy, improving the retention within a prehabilita-
ion programme thereby extending its potential benefits in
he run up to ASCT. However, local rehabilitation would not
e able to offer specialist services for this complex patient
roup, and may therefore require support from specialist
ervices.
It is now highly relevant to test whether digitally enhanced
nformation and communication technologies can promote
 more self-care or directed care model [25,26], thereby
roviding the means for on-going real time direction or
elegation and review from medical and rehabilitation
pecialists.
onclusion
This feasibility study has demonstrated that it would be
ossible to undertake a fully powered multi centred RCT
o investigate a prehabilitation intervention for patients with
yeloma due to undergo ASCT. There were both objective
nd subjective benefits, from both physical and a psycholog-
cal perspectives, which could potentially benefit myeloma
atients during a phase in their treatment associated with the
tart of ‘deconditioning’. However, evaluation of digitally-
nhanced directed but remote rehabilitation models of care
or this patient group is warranted before embarking on a full
rial.
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